Dr. David Patten, M.D
NPI: 1841463114
Total Payments
$12,710
2024 Payments
$2,011
Companies
34
Transactions
732
Medicare Patients
4,749
Medicare Billing
$589,721
Payment Breakdown by Category
Food & Beverage$12,615 (99.2%)
Education$95.49 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,615 | 729 | 99.2% |
| Education | $95.49 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $3,476 | 227 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,285 | 127 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $925.51 | 63 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $810.28 | 30 | $0 (2024) |
| Grifols USA, LLC | $770.63 | 49 | $0 (2024) |
| GENZYME CORPORATION | $748.69 | 30 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $489.27 | 25 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $430.62 | 26 | $0 (2020) |
| Mylan Specialty L.P. | $349.16 | 19 | $0 (2024) |
| United Therapeutics Corporation | $229.18 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,011 | 100 | GlaxoSmithKline, LLC. ($376.34) |
| 2023 | $2,277 | 116 | GlaxoSmithKline, LLC. ($484.77) |
| 2022 | $2,096 | 112 | AstraZeneca Pharmaceuticals LP ($511.59) |
| 2021 | $737.31 | 44 | GlaxoSmithKline, LLC. ($278.67) |
| 2020 | $962.41 | 61 | GlaxoSmithKline, LLC. ($398.54) |
| 2019 | $1,767 | 110 | GlaxoSmithKline, LLC. ($530.86) |
| 2018 | $1,298 | 91 | GlaxoSmithKline, LLC. ($433.81) |
| 2017 | $1,561 | 98 | GlaxoSmithKline, LLC. ($485.73) |
All Payment Transactions
732 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Pulmonology | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $9.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.31 | General |
| Category: Medical Device | ||||||
| 10/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Inflammation | ||||||
| 10/17/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $33.49 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Airway Clearance Device | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,193 | 1,814 | $485,834 | $153,496 |
| 2022 | 23 | 1,243 | 1,906 | $524,613 | $164,557 |
| 2021 | 20 | 1,068 | 1,673 | $442,286 | $140,889 |
| 2020 | 22 | 1,245 | 1,782 | $427,922 | $130,778 |
Total Patients
4,749
Total Services
7,175
Medicare Billing
$589,721
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 323 | 531 | $164,079 | $45,923 | 28.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 129 | 366 | $91,866 | $33,837 | 36.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 73 | 188 | $102,084 | $31,426 | 30.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 90 | $39,420 | $11,949 | 30.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $6,138 | $5,068 | 82.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 47 | $15,651 | $4,591 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $12,240 | $3,471 | 28.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $8,100 | $2,533 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 40 | $8,760 | $2,309 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $8,262 | $2,168 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 16 | $5,760 | $1,558 | 27.1% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 14 | $3,822 | $1,182 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 19 | $3,325 | $1,174 | 35.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 14 | 14 | $1,092 | $1,007 | 92.2% |
| 99407 | Smoking and tobacco use intensive counseling, more than 10 minutes | Office | 2023 | 26 | 37 | $2,590 | $991.60 | 38.3% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 30 | 37 | $2,405 | $961.80 | 40.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 84 | 84 | $2,520 | $756.70 | 30.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $1,610 | $666.77 | 41.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 84 | 84 | $1,932 | $563.03 | 29.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 87 | 87 | $1,827 | $537.12 | 29.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 16 | 16 | $1,120 | $463.84 | 41.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 16 | $544.00 | $159.30 | 29.3% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 12 | 13 | $507.00 | $133.98 | 26.4% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 12 | $180.00 | $68.19 | 37.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 285 | 440 | $136,484 | $39,800 | 29.2% |
About Dr. David Patten, M.D
Dr. David Patten, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Orleans, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1841463114.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Patten, M.D has received a total of $12,710 in payments from pharmaceutical and medical device companies, with $2,011 received in 2024. These payments were reported across 732 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($12,615).
As a Medicare-enrolled provider, Patten has provided services to 4,749 Medicare beneficiaries, totaling 7,175 services with total Medicare billing of $589,721. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Pulmonary Disease
- Location New Orleans, LA
- Active Since 04/08/2008
- Last Updated 07/05/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1841463114
Products in Payments
- TRELEGY ELLIPTA (Drug) $1,934
- DUPIXENT (Biological) $1,508
- ANORO (Drug) $616.20
- Prolastin-C Liquid (Biological) $582.80
- FASENRA (Biological) $573.69
- TEZSPIRE (Biological) $558.29
- NUCALA (Biological) $519.97
- SYMBICORT (Drug) $469.14
- OFEV (Drug) $408.49
- STIOLTO RESPIMAT (Drug) $339.76
- BREO (Drug) $318.55
- FASENRA (Drug) $318.54
- OPSUMIT (Drug) $249.10
- Yupelri (Drug) $218.59
- BREZTRI (Drug) $210.66
- TUDORZA PRESSAIR (Drug) $193.12
- Prolastin-C (Biological) $187.83
- BEVESPI AEROSPHERE (Drug) $177.26
- Adempas (Drug) $175.15
- Arikayce (Drug) $144.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New Orleans
Dr. Rima El-Abassi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $255,887
Student in an Organized Health Care Education/Training Program $255,887
Dr. Patrick Greiffenstein, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $214,722
Student in an Organized Health Care Education/Training Program $214,722
Veronica Gillispie, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $126,771
Student in an Organized Health Care Education/Training Program $126,771
Michael Bernard, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $121,414
Student in an Organized Health Care Education/Training Program $121,414
Nicole Lapinel, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $114,205
Student in an Organized Health Care Education/Training Program $114,205
Lingling Du, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $94,740
Student in an Organized Health Care Education/Training Program $94,740